These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36549404)

  • 1. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
    Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
    Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
    J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
    Wilson VR; Mugheirbi NA; Mosquera-Giraldo LI; Deac A; Moseson DE; Smith DT; Novo DC; Borca CH; Slipchenko LV; Edgar KJ; Taylor LS
    Mol Pharm; 2021 Mar; 18(3):836-849. PubMed ID: 33539105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
    Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
    Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser diffraction as a powerful tool for amorphous solid dispersion screening and dissolution understanding.
    Paisana MC; Lino PR; Nunes PD; Pinto JF; Henriques J; Paiva AM
    Eur J Pharm Sci; 2021 Aug; 163():105853. PubMed ID: 33865976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.